Dermapharm Holding SE

€38.00As of Sun 8 Nov 2026, 12:00 UTC
XETRA:DMPHealthcare
Country Germany
PE (Fwd) •••
TSR 9Y CAGR 6.67%
Div yield 2.32%
ROE 25.57%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.85
PE TTM 13.71
TSR TTM 13.37%
Mkt cap €1.883B
ROIC 12.31%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€40
4.59%
(83.00%)
Hold 9|2|5|7|10
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.56
0.58
0.60
0.58
16.07%
20.40%
13.36%
2.23%
Revenue€M
102.6
107.1
108.0
113.1
4.40%
10.85%
7.02%
9.78%
Peers (US$2.114B)
Cap (US$)
PE
631.5M
—
137.0M
2.520x
121.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.868
0.185
0.158
EBIT/Intx
1.518
0.062
0.071
Own earn%
(93.20)
14.98
(3.42)
Sh yield%
28.47
40.11
41.06
Owners
Insiders/Inst%
0.26
77.74
Short interest%
4.60
SBC / revenue%
4.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
3–11
$1 testx
—
Incr. ROIC%
5